Shares of Ampliphi Biosciences Corp (NYSEAMERICAN:APHB – Get Free Report) crossed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $0.00 and traded as high as $2.40. Ampliphi Biosciences shares last traded at $2.40, with a volume of 2,584 shares traded.
Ampliphi Biosciences Stock Performance
About Ampliphi Biosciences
AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant infections using bacteriophage-based technology. The company is involved in developing AB-SA01 for the treatment of staphylococcus aureus (S. aureus) infections; and AB-PA01 for the treatment of pseudomonas aeruginosa (P.
See Also
- Five stocks we like better than Ampliphi Biosciences
- 3 REITs to Buy and Hold for the Long Term
- Taiwan Semiconductor Stock: Buy Now or Wait for Earnings?
- Best Stocks Under $5.00
- Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
- The 3 Best Fintech Stocks to Buy Now
- Citigroup Faces Growing Troubles: Could the Industry Be at Risk?
Receive News & Ratings for Ampliphi Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
